The Regen BioPharma Inc (OTC: RGBP) stock had emerged as one of the biggest gainers last week, but it was a bit of a sobering experience for the investors on Monday.
The stock displayed considerable volatility on Monday and ended the day 19% in the red after having declined by 38% earlier on in the day. The Regen BioPharma stock gained a staggering 3800% in a matter of three sessions last week after it announced that it signed a licensing deal in relation to its pancreatic cancer treatment.
Last Wednesday, the stock rallied again after having gone down a bit. In addition to that, it is also necessary to note that the trading volumes in the stock went higher as well. More than 1 billion shares of the Regen stock were traded last Wednesday. In light of the latest slump, investors could consider keeping an eye on the stock and see if it can recover today.
Editor and Computer Expert
A hardcore tech enthusiast and computer expert Uson Abdilazhanov who holds a degree in communications started writing in his personal blogs since 2012. That time he was interested in the technical part of the computer. But now the software aspect plays an important role in his career. Currently, he runs a PC building and repairing shop which helps a lot of designers and gamers who always like to try new things.